Fenitrothion (Sumithion) Poisoning-Related Fasciculations Successfully Managed With Levetiracetam: A Case Report.

fasciculations fenitrothion levetiracetam organophosphate poisoning

Journal

Journal of acute medicine
ISSN: 2211-5587
Titre abrégé: J Acute Med
Pays: China (Republic : 1949- )
ID NLM: 101574304

Informations de publication

Date de publication:
01 Jun 2024
Historique:
received: 31 05 2023
accepted: 13 06 2023
medline: 10 6 2024
pubmed: 10 6 2024
entrez: 10 6 2024
Statut: ppublish

Résumé

Fenitrothion is one of the most globally used organophosphorus pesticides, which can cause neurological symptoms, including involuntary movements. However, due to the limited number of case report, information on its treatment is also scarce. Here we presented a 74-year-old Japanese woman who was admitted to our hospital due to a persistent nausea and vomiting after ingesting 200 mL of 50% fenitrothion for a suicidal attempt. She received continuous intravenous infusion of atropine and 2-pyridine aldoxime methiodide under mechanical ventilation and continuous hemodiafiltration. However, she developed fasciculations of the face and right arm on day 11, which raised suspicions of delayed neuropathy associated with organophosphorus poisoning. To reduce the risk of respiratory depression, she received intravenous levetiracetam at a dosage of 1,000 mg/day. However, as her fasciculations persisted, the levetiracetam dosage was adjusted to 2,000 mg/day on day 14. On the following day, her fasciculations subsided. Neurologic symptoms of lipid-soluble organophosphorus poisoning, including fenitrothion, can sometimes delay following ingestion. Temporary administration of levetiracetam may prove effective in alleviating fasciculations.

Identifiants

pubmed: 38855047
doi: 10.6705/j.jacme.202406_14(2).0004
pmc: PMC11153314
doi:

Types de publication

Journal Article

Langues

eng

Pagination

90-93

Auteurs

Hiroshi Ito (H)

Department of Internal Medicine Division of General Internal Medicine Tokyo Medical University Ibaraki Medical Center, Ibaraki Japan.

Toshiya Nakashima (T)

Department of Internal Medicine Division of General Internal Medicine Tokyo Medical University Ibaraki Medical Center, Ibaraki Japan.

Satoshi Kobanawa (S)

Department of Internal Medicine Division of General Internal Medicine Tokyo Medical University Ibaraki Medical Center, Ibaraki Japan.

Jura Oshida (J)

Department of Internal Medicine Division of General Internal Medicine Tokyo Medical University Ibaraki Medical Center, Ibaraki Japan.

Taisuke Kodama (T)

Department of Internal Medicine Division of General Internal Medicine Tokyo Medical University Ibaraki Medical Center, Ibaraki Japan.

Sayato Fukui (S)

Department of Internal Medicine Division of General Internal Medicine Tokyo Medical University Ibaraki Medical Center, Ibaraki Japan.

Daiki Kobayasi (D)

Department of Internal Medicine Division of General Internal Medicine Tokyo Medical University Ibaraki Medical Center, Ibaraki Japan.

Classifications MeSH